By Business/Source
Currency:USD
2026/Q1
Stock NameRevenueRatio
Developing its proprietary Ribonucleic acid (RNA) medicines platform, PRISM, to develop and38.25M100.00%
By Country/Region
Currency:USD
2025/FY
Stock NameRevenueRatio
Singapore42.73M100.00%